Last reviewed · How we verify

NCT06274931

Analysis of the Pulmonary Microbiome

Status unknown Last updated 23 February 2024
What this trial tests

trial testing Bronchoscopy in Pneumonia in 30 participants. Status unknown.

Timeline
1 February 2024
Primary endpoint
20 February 2024
20 June 2024

Quick facts

Lead sponsorUniversity Magna Graecia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 February 2024
Primary completion20 February 2024
Estimated completion20 June 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University Magna Graecia

Who can join

18 and older, any sex, with Pneumonia or Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the protocol is to study the pulmonary microbiome in patients who develop pneumonia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bronchoscopy

Trials testing the same drug.

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

Other University Magna Graecia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06274931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing